Study Explores Why Prostate Cancer Mortality is Higher in Black Men

The largest study of its kind finds societal factors and access to quality care, rather than genetics, underlies higher prostate cancer mortality rates for black men.

11:50 AM

Author | Jordyn Imhoff


Black men are more likely to be diagnosed with prostate cancer and nearly 2.5 times more likely to die of the disease compared to non-Hispanic white men. The question is why. Are black men more likely to carry genes that drive deadlier forms of the disease? What societal disparities might be affecting outcomes?

In a new JAMA Oncology study, a team led by the U-M Rogel Cancer Center analyzed data from more than 300,000 prostate cancer patients in order to better understand outcomes and what factors might be driving them.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

For example, in addition to their prostate cancer diagnosis, black men were more likely to have cardiovascular disease and obesity, which can separately shorten their lifespans, says study co-senior author Daniel Spratt, M.D., co-Chair of Genitourinary Clinical Research at U-M.

"The data show that black men don't appear to intrinsically and biologically harbor more aggressive disease," Spratt says. "They generally get fewer PSA screenings, are more likely to be diagnosed with later stage cancer, are less likely to have health insurance, have less access to high-quality care and other disparities that can be linked to a lower overall socioeconomic status."

Spratt adds, "While our job is to treat cancer, we know that these other factors are in play, so as doctors we need to make sure we focus on the health of the entire patient and, as a society, on addressing racial inequities."

Better data

In the largest and most comprehensive study of its kind, the researchers assessed data from a large, population-based cohort from the National Cancer Institute, as well as multi-center data from the Veteran's Affairs heath system and data from four randomized clinical trials sponsored by the National Cancer Institute.

Black men don't intrinsically and biologically harbor more aggressive disease.
Daniel Spratt, MD

The large, population-based dataset — known as Surveillance, Epidemiology, and End Results, or SEER — had previously been used to suggest that there were underlying genetic factors behind differences in outcomes seen in blacks and whites in the US, since the data didn't account for multiple variables.

The additional data and analysis in the U-M study suggest external factors are more likely the cause, the researchers say.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Using patients from the VA allowed the researcher to look at a group with more similar baseline characteristics, one that has equal access to healthcare, the authors note. Additionally, in the randomized trial data, comparison is improved because patients are given specified treatment regimens and have regular follow-up, often for more than 10 years.

Looking across all of these datasets provides a more accurate picture of whether race, independent of other social factors, leads to different health outcomes.


The study's researchers found that black men did not have an increased risk of dying from prostate cancer compared to white men with a similar stage of disease. On a population level, the disparities in death rates appear to mostly, if not entirely, be attributed to external circumstances.

However, even when adjusting for variables, it was clear across the three datasets that black men die more often from other causes like heart disease compared to white men. Therefore, the greatest disparity to black men with prostate cancer is access to quality healthcare and guideline concordant care that are likely rooted in complex socio-cultural inequities in the US.

The clinical trials data even suggested that black men had a lower prostate cancer mortality rate than white men — meaning that on a stage-for-stage basis black men might have higher cure rates than white men when treated with radiation therapy. So, Spratt encourages providers to be cautious about misinterpreting the SEER population results updated each year.

"Why black men are diagnosed more often with prostate cancer is something that requires further investigation," he says.

The study was co-led by first authors: Robert Dess, MD, Holly Hartman, MS, from U-M and Brandon Mahal, MD, from Masschusetts General Hospital. The other co-senior author was Matthew Schipper, PhD, from U-M.

Conflict of Interest Disclosure: Daniel Spratt reported receiving personal fees from Janssen Pharmaceuticals and Blue Earth outside the submitted work.

More Articles About: Lab Report Prostate Cancer Basic Science and Laboratory Research Cancer Research Race and Ethnicity Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories supar molecule teal blue yellow red
Health Lab
Immune protein suPAR links viral infection as possible cause of kidney disease
Through a series of experiments in non-human primates, mice and humans, a multi-institutional team led by researchers from Michigan Medicine and Rush University found that the immune protein soluble urokinase plasminogen activator receptor, or suPAR, is an important link between viral infections and proteinuria; the elevation of protein in the urine is known to cause glomerulopathy, a common form of kidney disease.
doctor with patient white and black patient ignored
Health Lab
Fixing racial inequities in lupus care
When it comes to lupus care, Black adults are normally left behind despite being one of the highest lupus populations.
Health Lab
Managing scleroderma symptoms through a team approach
Research published in the Arthritis Care and Research Journal from Michigan Medicine found that scleroderma patients made significant strides when working with trained peer health coaches in adhering to wellness routines, leading to resilience and improvements in fatigue, pain and depressive symptoms.
white bowls with allergens in each one
Health Lab
Measuring skin water loss predicts anaphylaxis during food allergy tests
Measuring skin water loss during food allergy tests may help predict anaphylaxis and keep patients safe. The method aims to detect the life threatening reaction before epinephrine injections are necessary
grey needle into cell blue
Health Lab
Mouse model of gender-affirming testosterone treatment and fertility finds decrease in egg yield but not quality
The current IVF recommendation is for transgender patients to stop taking gender-affirming hormones before the procedure, which can be costly and life changing. Now, a team of researchers are diving in further to investigate what the best recommendations should be based on more evidence.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
Dementia at the End of Life
Over thirty percent of individuals living with dementia living in the US each year die either of or with dementia – and almost half of those enrolled in hospice have dementia. As with so many other types of healthcare, there are disparities in both who enrolls in hospice as well as the type of care these individuals receive after enrollment. In this episode, Matt & Donovan talk with Dr. Lauren Hunt from UCSF, an expert in hospice care for persons living with dementia, about dementia at the end of life.